Temasek-backed China genomics firm targets raising up to $200 mln, say sources: Reuters

A Temasek-backed Chinese genomics firm has kicked off its latest fundraising round with a target of up to $200 million, drawing interest from investors including Hillhouse Capital Group and Sequoia Capital China, sources told Reuters

DealsNorth AmericaUSBriefs